Facilitating European Clinical Research

ECRIN is a public, non-profit organisation that links scientific partners and networks across Europe
to facilitate multinational clinical research. We provide sponsors and investigators with advice,
management services and tools to overcome hurdles to multinational trials and enhance collaboration.

Our Work

We provide our 12 member and observer countries with diverse trial support services
and contribute to 'infrastructure development' projects with additional European and international partners.

ECRIN in Numbers

Member & Observer Countries

Million citizens represented

Trials in ECRIN portfolio

Average # of countries per trial



ECRIN's Czech National Partner, CZECRIN, invites you to join the CZECRIN Annual Research Conference 2022. One focus area will be on international operations and it will be held in English. It will include information on ECRIN, EUPATI, Vaccelerate in the Czech Republic as well as CONSIOUS II – a project that focuses on education in the field of clinical trials. More information will be published on the CZECRIN website.  

For more information visit the CZECRIN website 

Or register today 


The famous physicist Stephen Hawking recognised that “our future is a race between the growing power of our technology and the wisdom with which we use it”. The remarkable advances in the fields of artificial intelligence (AI) and machine learning (ML) over the past few years have attracted considerable attention – and fuelled fears. This year’s SCTO Symposium takes a closer look at this topic from various perspectives.

We have worked closely with Ente Ospedaliero Cantonale (EOC) in Lugano to put together a programme that is rich in variety. Along with other leading experts, we have invited Professor Michael Bronstein to speak at the symposium. Bronstein is a DeepMind Professor of Artificial Intelligence at the University of Oxford in the UK and a global leader in the field of geometric machine learning, a field that has recently found a wide range of applications from recommender systems to drug development.

We will use presenters’ contributions and practical national and international examples to take a closer look at the following questions:

  • To what extent is the use of AI and ML in clinical research already a reality?
  • How can the use of AI and ML benefit clinical research? What kind of clinical research is needed to validate its use?
  • What are the opportunities, challenges, and risks of these new approaches?
  • With every new technology, the question of regulation inevitably arises. How much regulation is needed, and what (new) ethical questions need to be answered?
  • How do key Swiss stakeholders in clinical research currently address these new technological advances and how are they preparing for the future?

The symposium will be held in English.
The programme of the SCTO Symposium 2022 with more information is available below.

Online registration

See full program here


The aims of EuroGCT’s first one-day workshop on sharing best practice in public engagement and communicating about gene and cell therapy will be:

  • To facilitate the sharing of best practice amongst the EuroGCT partnership.
  • To support EuroGCT partners in their professional development so that they can then deliver training/innovative public engagement initiatives within their own localities. 
  • To foster a network of public engagement professionals amongst the partnership.
  • To collectively review the project's communication activities to date and plan for next steps.
  • To plan for future capacity-building workshops, including identifying objectives, topics, potential host organisations, and forming a planning committee.

Registration by 30 April: https://edinburgh.onlinesurveys.ac.uk/eurogct-workshop-2022


Who is this workshop for?

1. We would encourage everyone in engagement and communication roles, including outreach managers, engagement professionals and communication officers, to attend this workshop.

2. Researchers at any stage of their career with specific interest and experience in, and/or responsibility for, gene and cell therapy-related engagement are also very welcome to attend.

Please complete the registration survey by 30 April, because the programme is shaped based on participant contributions and feedback. The survey will remain open in May and early June for last-minute registration to receive the Zoom link, but please register as early as possible to help us finalise the programme.

Please note this workshop is not intended as an introduction to public engagement for those without experience. However, we have identified a need to support early-career researchers (ECR) starting out in public engagement. An ECR component is planned as part of an extended programme for future workshops.